ArticleThe oncologist2021

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.

Laura A Sena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.